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Abstract
Background: Psychosis often causes significant distress and impacts not only in the individuals, but also those close to
them. Many relatives and friends (‘carers’) provide long-term support and need resources to assist them. We have co-
produced a digital mental health intervention called COPe-support (Carers fOr People with Psychosis e-support) to
provide carers with flexible access to high quality psychoeducation and interactive support from experts and peers. This
study evaluates the effectiveness of COPe-support to promote mental wellbeing and caregiving experiences in carers.
Methods: This study is a single-blind, parallel arm, individually randomized controlled trial (RCT) comparing COPe-support,
with attention control. Both groups continue to receive usual care. COPe-support provides interactive web-based
psychoeducation on psychosis-related issues, wellbeing-promotion and network support through forums. The attention-
control is a non-interactive online information resource pack. Carers living in England are eligible if they provide at least
weekly support to a family member or close friend affected by psychosis, and use internet communication (including
emails) daily. All trial procedures are run online, including collection of outcome measurements which participants will
directly input into our secure platform. Following baseline assessment, a web-based randomization system will be used to
allocate 360 carers to either arm. Participants have unlimited access to the allocated condition for 40 weeks. Data
collection is at three time points (10, 20, and 40weeks after randomization). Analyses will be conducted by trial
statisticians blinded to allocation. The primary outcome is mental wellbeing measured by Warwick Edinburgh Mental
Wellbeing Scale (WEMWBS), at 20 weeks. As well as an intention-to-treat analysis, a complier average causal effect (CACE)
analysis will be conducted to estimate the intervention effect in participants who have accessed COPe-support content
twice or more. The secondary objectives and analysis will examine other health and caregiving-related outcomes and
explore mechanisms. In a process evaluation, we will interview 20% of the intervention arm participants regarding the
acceptability of COPe-support. We will explore in detail participants’ usage patterns.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: jasin@sgul.ac.uk
1Population Health Research Institute, St George’s, University of London,
Cranmer Terrace, London SW17 0RE, England, UK
2School of Psychology & Clinical Language Sciences, University of Reading,
Earley Gate, Reading RG6 6AL, England, UK
Full list of author information is available at the end of the article
Sin et al. BMC Psychiatry          (2020) 20:129 
https://doi.org/10.1186/s12888-020-02528-w
(Continued from previous page)
Discussion: The results of this trial will provide valuable information about the effectiveness of COPe-support in
promoting wellbeing and caregiving experiences in carers.
Trial registration: The RCT is registered with the Current Controlled Trials registration (ISRCTN 89563420, registration
date: 02/03/2018).
Keywords: eHealth, eMentalHealth, Digital interventions, Carers, Psychosis, RCT, Wellbeing
Background
World-wide, an ever-increasing population is living
longer in the community despite long-term illness. In
addition to the advances of health care, one crucial
element that support and sustain this population in their
own home is the unpaid care and support provided by
relatives and friends [1]. In the UK, it is estimated that
approximately 1.5 million people are caring for a family
member or friend with a mental illness [2–4]. Of these
illnesses, psychosis is recognised as among the most
common and severe [2, 3]. Often, people with psychosis
require long-term treatment and support across a range
of life domains, including emotional support, financial and
practical assistance for daily living activities [5, 6]. There-
fore, the importance of relatives and friends - referred to
carers hereafter - is well established. Extant research evi-
dence has established that individuals who receive support
and care from their familial networks have a better prog-
nosis and enhanced quality of life [3, 7, 8]. Conversely, the
responsibility of caring often means that carers of people
with psychosis experience high levels of distress and
increased vulnerability to ill health [9–12]. Furthermore,
carers’ psychiatric morbidities are shown to be inversely
correlated with the amount of care they provide; that is,
the higher amount of care provided leading to poorer
mental health [13]. Poor mental health in carers can
further negatively impact their caregiving capacity [9, 14].
Carers who are unwell themselves or feel they lack re-
sources to cope are less likely to engage in caring for their
loved ones in a positive manner [6].
Consequently, a body of research has been undertaken
to establish psychosocial interventions which can best
support carers [5, 6, 15]. Among these, psychoeducation
(i.e. information-giving on the illness condition and
related caregiving and problem-solving strategies) espe-
cially those integrated with a peer support element
between carers in a group setting, has the strongest
evidence base for its effectiveness in enhancing carers’
knowledge and coping with their caring roles [2, 16].
Carers also identify that sharing mutual support and
learning with other carers as particularly useful in redu-
cing their sense of isolation [5, 16]. In the UK, psycho-
education is recommended by the National Institute for
Health and Care Excellence (NICE) guidelines on psy-
chosis and schizophrenia for all carers [2].
With digital health interventions becoming more wide-
spread and popular across a range of public mental
health topics in the recent time, interventions targeting
carers supporting a loved one with long-term illness
have increasingly adopted an online medium [15, 17].
Many carers lead a busy lifestyle with multiple commit-
ments in addition to caregiving. Digital interventions are
potentially flexible, accessible and yet adaptable to indi-
vidualized needs and schedule. Such interventions, using
an enriched and dynamic online environment, are par-
ticularly suited to delivering psychoeducation, wellbeing
promotion strategies, and network support with health-
care professionals and peers [18–20].
Emerging research provides increasing evidence to
promote digital mental health (or e-mental health) as an
effective means to disseminate interventions to carers
[15]. Across a wide range of long term illnesses, there is
a particularly strong evidence base for psychoeducational
interventions treating mental health morbidities in carers
of people with dementia, stroke, and cardiovascular dis-
eases. In contrast, both the volume of literature and re-
search evidence are less established in mental health
arena, with the exception of eating disorders [15, 19, 21].
Few such interventions are available for psychosis carers
and even fewer have been trialled rigorously [17]. Hence,
the EFFIP (E-support for Families and Friends of Individ-
uals affected by Psychosis) Project was established to fill
these research gaps to develop and evaluate a digital
health intervention for carers supporting a relative or close
friend with psychosis [22]. The EFFIP project is a five-year
research programme encompassing theoretical develop-
ment work and participatory research to develop the
digital health intervention which is then evaluated for ef-
fectiveness in promoting carers’ wellbeing [5, 6, 17]. The
participatory study through which the intervention, called
“COPe-support (Carers fOr People with Psychosis e-
support)” was co-produced, is published elsewhere [22].
COPe-support provides high quality psychoeducation and
interactive support to carers entirely through the internet,
promoting flexible access and individualized choice of
content, pace, and engagement for its users [22]. It is ex-
pected that, if effective, COPe-support can help overcome
some of the barriers associated with implementing
evidence-based psychosocial interventions. These include
lack of resources to prioritise carers’ needs on a par with
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those they care for, stigma, accessibility, and the mis-
match between the conventional face-to-face service
provision and the diverse needs of carers [6, 17, 22].
There is a strong argument that interventions deliv-
ered online should also be evaluated online to maximize
the trial’s external validity and some aspects of internal
validity [23]. Firstly, it is of interest to establish whether
the profile of carers using a digital intervention is repre-
sentative of the wider populations, including those using
conventional services (such as face-to-face carers groups,
individual psychological intervention). Secondly, as COPe-
support is delivered entirely online and requires the carers
to self-pace and self-tailor the multiple components suit-
ing their own needs and schedule, it is only logical to col-
lect evaluation data directly from them using an online
medium. Thirdly, while arguably the web-based media of-
fers a low-cost platform through which the intervention
can be delivered to a critical mass with a high level of fi-
delity to its design, research on online trials show that they
can be inferior to conventional trials in terms of adher-
ence and retention rates [17, 23–25]. It is important for
both the trial and the facilitation of COPe-support to
consider effective strategies to engage with carers in
line with its online delivery. Finally, as digital inter-
ventions allow their users a self-directed approach in
using the content, intervention usage or adherence is
often very heterogenous. It is important to explore
the differential benefits of the intervention use in par-
ticipants with different usage patterns [26–28].
The proposed COPe-support trial aims to evaluate the
clinical effectiveness of COPe-support in promoting
mental wellbeing and caregiving experiences in relatives
and close friends who support a loved one affected by
psychosis.
Study aims and objectives
This trial aims to determine the effectiveness of the
COPe-support intervention and usual care (UC), com-
pared with a non-interactive web-based information
resource (which is also provided within COPe-support)
and usual care. The comparator is an attention-matched
control while also representing the current online
resources widely available to carers.
Further objectives include:
 To determine the effects of COPe-support on carers’
mental wellbeing;
 To determine the effects of COPe-support on carers’
mental health knowledge, perceived support, ap-
praisal of caregiving experiences, expressed emotion,
and quality of life;
 To explore the intervention effects of COPe-support
on hypothesized mechanisms of change through
impacts on carers’ knowledge, perceived support,
and appraisal of caregiving;
 To assess the relationship between usage of COPe-
support and effectiveness in carers’ outcomes; and
 To determine the acceptability of COPe-support as
perceived by carers.
Study hypotheses
The primary hypothesis is that COPe-support is superior
to the attention-matched control with respect to im-
proving carers’ mental wellbeing, measured using War-
wick Edinburgh Mental Wellbeing Scale (WEMWBS
[29]) at the end of intervention use of 20 weeks (primary
end point). Secondly, it is hypothesized that relative to
the control group, COPe-support participants will have
better mental health knowledge, appraisal of their care-
giving experiences, perceived support, and quality of life,
at all follow-up time points.
Methods
Trial design
The study is an online randomized controlled trial
(RCT) with an embedded internal pilot RCT to verify re-
cruitment and retention; and a full RCT. The overall
RCT uses a two-arm, individually randomized controlled
superiority trial design comparing COPe-support (in
addition to usual care) with an attention-matched con-
trol (in addition to usual care).
Internal pilot
The trial includes a 12-month internal pilot to establish
that study procedures work well to recruit and retain
participants, and check that a good proportion of partici-
pants use the intervention. The definition of use is a par-
ticipant who has activated their log-in and have accessed
their allocated condition at least once. The internal pilot
progression criteria include:
 Go: at least 80% of one-third of the sample size (i.e.
120) are recruited, and at least 80% of these partici-
pants have met the usage requirement and are
retained in the study by 20 weeks (primary end
point)
 Amend and review: If any of the recruitment,
usage and retention rates are below 80%
We were required to achieve the above criteria by the
end of the initial 12 months for the trial to proceed into
the full study. In the event of any of the recruitment,
retention, or usage thresholds not being met, we would
have worked together with the Trial Steering Committee
to review strategies for improvement. The internal pilot
study was successful with all the “Go” criteria met prior
to the deadline, and hence it proceeded into the next
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stage with further recruitment sites set up and recruit-
ment strategies scaled up for a further year.
Setting and participants
The study will recruit adult carers who provide ongoing
care and support for a relative or close friend affected by
psychosis (including Type 1 bipolar disorder in addition
to all diagnoses covered by the NICE guideline on
psychosis and schizophrenia [2]) on an unpaid basis.
Both the carers and the cared-for individuals need to
reside in England, UK.
Eligibility criteria
Inclusion criteria include family members, relatives or
close friends who:
 Are aged 18 or over;
 Have at least weekly contacts with the cared-for per-
son, in any form ranging from face-to-face to social
media communications;
 Living in England during the study period;
 Able to communicate in English in usual online
communications; and
 Have daily access to the internet including emails.
To avoid a clustering effect, we can only include one
carer per cared-for individual in the trial. Therefore, we
exclude potential participants who have another relative
or friend, already enrolled in the study, sharing the
caring role for the same person.
Interventions
Active intervention: COPe-support
The intervention condition, COPe-support, is delivered
through a web-based virtual learning environment (VLE)
called Canvas (https://www.canvasvle.co.uk). The VLE
allows the participants to access the intervention online
via desktop or laptop web browsers, as well as smart-
phones or tablets through a Canvas app. COPe-support
was co-produced through participatory research with a
wide range of experts through experience or through
professional training, building upon results identified
through systematic reviews of the literature and a focus
group study with carers and people affected by psychosis
[6, 17, 22]. After the COPe-support prototype was
finalized, we ran a mixed-method study to establish its
feasibility and usability with a small sample of carers and
technical expert. We also gleaned further usage and
qualitative feedback from the usability study to refine
the content and facilitation strategy of COPe-support
[30]. These have been incorporated to develop and revise
the delivery and facilitation strategies of the RCT, as
reported in this protocol.
Delivered through an online enriched environment plat-
form, COPe-support is a multi-component digital inter-
vention providing psychoeducation and network support
function with peers and experts. After logging in, carers
will automatically enter into the Home page showing a
brief introduction and a grid-based visualization repre-
senting the intervention menu [22, 30]. From here, carers
can access and download a navigation video or equivalent
textual guide. Using a mixture of textual and audio-visual
materials devised by the study team with contributions
from expert members, COPe-support content is grouped
into 12 broad sections [22, 30]. These include:
 six sections of psychoeducation focusing on
psychosis, its treatment, and related caring issues;
 two sections on wellbeing promotion information
and exercises directed at carers themselves;
 two online forums, one called “Ask the Experts”
where carers can post questions for advice from a
panel of experts, and the other called “Peer to Peer”
where carers exchange views with one another;
 a “Resources for carers” section with supplementary
weblinks to a wide range of relevant external
resources; and
 a “Support” section where participants can get in
contact for technical or emotional support directly.
The content of COPe-support is summarized in Table 1.
Figure 1 provides screenshots of various sections of
COPe-support.
Throughout the study period, an online facilitator (JS)
who is an experienced mental health nurse, monitors
and moderates all the interactive functions of COPe-
support. These include the forums and the inbuilt com-
munication weblinks such as messages the participants
can send through COPe-support platform asking for
support or seeking information. The online facilitator
also coordinates a panel of 14 expert panel members
comprising psychiatrists, GPs, pharmacists, benefits ad-
visors, CBT therapists, social worker, mental health
nurse, and Expert through Experience, behind the oper-
ation of the “Ask the Experts” forum. Once a week, the
facilitator also posts an update via the COPe-support an-
nouncement function to all participants with an aim to
keep them engaged. In parallel to the announcement
appearing on COPe-support platform, an email will
automatically be generated to each of the participants.
For security and confidentiality considerations, partici-
pants are required to follow a set of ground rules in
using COPe-support [22]. These include the use of a
self-chosen pseudonym to anonymise participation in
communication and interactions online and adhering to
the confidentiality principles so not to include any of
their own and their cared-for individual’s person-
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identifiable details when making posts on either forum.
We provide guidelines with examples to explain what con-
stitute person-identifiable data and how participants can
fully participate in the interactive forums without giving
any such data away. If necessary, the facilitator can delete
or edit posts made by participants and moderate any
particular participants’ access to the forums [30].
Attention-matched control: web-based information bank
To control for the attentional component of COPe-
support and to account for the effects of online informa-
tion provided by websites run by statutory and voluntary
organisations as part of usual care, we developed a
Table 1 Summary of COPe-support content
Section title Content
Understanding psychosis An overview of psychosis
including common symptoms
and co-occurring problems, a
bio-psychosocial explanatory
model of possible causes, and
prognosis.
Treatment of psychosis Information on evidenced-
based pharmacological,
psychological, social, and
alternative treatment for
psychosis, with reference
to the NICE guidelines.
Caring for your loved one Information on caregiving,
communication, and problem-
solving strategies for a range
of common symptoms and
related issues, such as:
supporting your loved one
with paranoid beliefs; and
working out a relapse
prevention plan.
Getting through services Information on the health,
social and wider service
systems and ways to
navigating through them
for support for their loved
ones and the carers themselves.
Ways to promote recovery It describes how carers can help
support their loved ones to live
their life to the full and gives
information on a variety of
support resources through the
healthcare and wider social
network.
Caring for carers Focusing on carers themselves,
we share tips from other carers
with experiential expertise and
the literature in ways to look
after their own wellbeing,
including interactive resources
(such as podcasts) promoting
wellbeing.
Stigma and discrimination Information on stigma and
discrimination commonly faced
by individuals with psychosis
and those close to them. We
give information on related
law and rights and suggest
ways and resources which
help deal with stigma and
discrimination.
Becoming a resilient carer This section helps carers to
reflect and draw together
relevant information and
skills gained for their caring
situation and for looking
after their own wellbeing.
It concludes with an
interactive plan where
carers can tailor-make their
own “caring for carer” plan
integrated with a wellbeing-
promotion toolkit.
Table 1 Summary of COPe-support content (Continued)
Section title Content
Peer to peer forum A virtual forum and blog
space for carers to share
experiences and discuss
commonly encountered
issues. It has seven topics
covering carer’s story and
various topics such as
difficult emotions and
way to come to terms
with them, and “taking
the positive things out
of the experience”.
Ask the experts forum An interactive forum
where carers can post
questions to an expert
panel. The forum is
organized around six
topics, including talking
therapies and psychosocial
interventions, and general
and physical health issues.
All other carers can also
post responses and
follow-up questions onto
the forum.
Resources for carers
(The control comprises
this section)
A live information bank
that covers a range of
relevant services and
resources with direct
weblinks. Categories of
resources include:
voluntary organisations;
relevant organization
providing mental health
information and support;
statutory health and
social care services; books;
online resources; health
research information; and
money matters advice.
Support (The control
comprises this section)
We provide a direct weblink
in this section where carers
can contact the study team
for emotional or technical
support. Information on
alternative relevant support
services, such as NHS 111 and
Samaritan are provided here.
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control intervention to have the identical look and “feel”
as the active COPe-support intervention. We created the
control condition mimicking the content of the Home
page, “Resources for Carers”, and the Support section
from the active intervention, also delivered through
Canvas VLE (see Table 1). However, there are much less
content and no interactive forums in the control nor any
wellbeing promotion content. Participants can get in
touch with the study team directly for support if neces-
sary, and the control also has the same communication
functionalities as the active intervention, hence partici-
pants will also be sent weekly updates. In order to encour-
age retention and follow-up data completion, we will offer
the participants allocated to the control access to COPe-
support for four months’ time, after final follow up data
collection. Screenshots of the control are shown in Fig. 2.
Procedures
Recruitment
We will recruit the participants from statutory mental
health services across England, i.e. NHS mental health
trusts which provide secondary mental health services
locally, typically for a population between three-quarters of
to one million. Furthermore, we will recruit through
national and local voluntary mental health organisations
(such as SANE http://www.sane.org.uk/ and Suffolk Family
Carers https://suffolkfamilycarers.org/).
Study promotion and recruitment activities across all
sites will include the research team presenting at rele-
vant events targeting carers and staff working with
carers. We will also disseminate flyers, posters, and study
information widely within various sites, through working
closely with the Clinical Research Network and local
staff who are supporting the study recruitment. Social
media advertising using twitter targeted at statutory and
voluntary organisations which carers commonly seek out
will also be utilized.
Further to the recruitment activities, all interested
carers are directed to our study website (www.cope-sup-
port.org/) which provides comprehensive study informa-
tion including the full participant information sheet
outlining the study aims, risks and benefits, confidential-
ity and dissemination of results. Potential participants
can register their interest in joining the study and
Fig. 1 Screenshots of COPe-support content. Detailed legend: Screenshots taken from COPe-support intervention platform
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undertake eligibility screening through the study website.
Those who meet all the eligibility criteria are then
guided through the online informed consent seeking and
study enrolment process. The study website also pro-
vides direct weblink for potential participants to post
any queries and get in touch with the study team.
We schedule all the participants recruited over a dur-
ation of two years (i.e. March 2018 to February 2020)
into six cohorts, each lasting eight months, as shown in
Fig. 3. This approach allows us to group at least 20 but
no more than 60 participants in the intervention plat-
form at any one time. This is to ensure that forum ele-
ments of the intervention - those requiring interactions
between participants – are accessed by an optimal num-
ber of participants [17]. Two weeks prior to each cohort
is due to start, consented participants are invited to
undertake a baseline measures through our secure
online platform. Those who have completed the baseline
measures will then be randomized to receive either
COPe-support or the attention-matched control. They
will be sent log-in details to access the respective
condition and instructions to download the free app
(Apple or Android) for those who want to use COPe-
support (or the control) on tablets or smart phones, in
addition to computers. The flow of participants through
the study phases is shown in Fig. 4.
Assessment
Primary outcome and measure
The primary outcome is carers’ mental wellbeing at 20
weeks assessed using Warwick Edinburgh Mental Well-
being Scale (WEMWBS [29]). WEMWBS is a self-report
measure comprising 14 short statements focusing on
positive wellbeing. Each statement is rated on a 5-point
Likert scale, resulting in the possible scores range
from 14 to 70 (higher score indicates better mental well-
being). Since its validation, WEMWBS has been widely
used in epidemiological studies, including the Health
Surveys in England and Scotland [11, 31, 32]. It has been
established that an increase of 3 points in WEMWBS is
a meaningful change post intervention, based on a wide
Fig. 2 Screenshots of the control condition. Detailed legend: Screenshots taken from the control platform
Month -3-0: Recruitment and enrolment.
Month 1-4: Each cohort runs for 20 weeks 
Month 5-8: Participants have access to either condition for a further 20 weeks until 40-week follow-up data collection completes 
Fig. 3 Schedule of cohorts. Detailed legend: Not applicable
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range of mental health intervention trials undertaken in
different populations [13, 33].
Secondary outcomes and measures
A range of secondary outcomes will be considered,
including changes in the following:
Carers’ mental health knowledge, measured using the
Mental Health Knowledge Schedule (MAKS [34]).
MAKS has two sections: the former to investigate partic-
ipants’ knowledge of mental health; the latter for contex-
tualising the responses. Possible scores range from 6 to
30 by summing up the scores of the first section of six
items. Higher scores of MAKS indicate better level of
mental health knowledge.
Carers’ appraisal of caregiving experience, assessed
using the Experience of Caregiving Inventory (ECI [8]).
There are 66 brief statements each requiring a rating on
a 5-point ordinal scale (from 0 = never to 4 = nearly al-
ways) in the ECI. These are categorized into ten sub-
scales; eight negative subscales summing into the total
negative appraisal total (possible scores range from 0 to
208; higher scores indicate poorer outcome), and two
positive subscales totaling into the positive appraisal
score (possible scores range from 0 to 56; higher the
scores better the positive perspective).
Carers’ wellbeing and perceived support, measured
with the Carers’ Wellbeing and Support Questionnaire
(CWS [35]). CWS contains two subscales: wellbeing
(higher scores indicate better wellbeing) and perceived
support (higher scores indicated lower satisfaction).
Criticism and emotional over-involvement in the family,
assessed by Family Questionnaire (FQ [36]). FQ com-
prises 20 short questions, with 10 of these covering
the criticism subscale, and the remainders the emo-
tional over-involvement subscale. Higher scores indi-
cate poorer outcomes on both subscales.
Carers’ quality of life assessed using Euro-QoL 5-level
(EQ-5D-5L [37]). EQ-5D-5L comprises two components:
health state description covering the domains of mobil-
ity, self-care, usual activity, pain/discomfort and anxiety/
depression; and an overall evaluation using a visual
analogue score (EQ-VAS). The EQ-VAS asks the partici-
pants to rate their subjective rating of health ranging
from 0 to 100, where 100 implies the best health one
can imagine, and 0 the worst.
Service use
In addition to these measures, service use information by
the participants will be collected to describe usual care.
Process evaluation outcomes and data
The trial has an inbuilt process evaluation study to ex-
plore participants’ usage patterns and subjective experi-
ence of participants in using COPe-support. In order to
understand when and how participants access and use
the online intervention, we will collect usage data which
COPe-support + Usual care (20 weeks) Control + Usual care (20 weeks)
Participants randomised to:
Excluded (e.g. not meeting 
all inclusion criteria)
COPe-support + Usual care
(40-week follow-up) 
Control + Usual care
(40-week follow up)
Recruitment through all potential referral routes
(including through NHS and voluntary carer 
organisations)
Eligibility screening 
Informed consent & baseline data collection
Not recruited or not eligible
Loss to follow 
Fig. 4 CONSORT flowchart showing participant pathway through the trial. Detailed legend: Not applicable
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the intervention and control platform automatically
monitors and records. These include:
 Number of log-ins on separate days per participant
(both arms)
 Average page views per log-in per participant (both
arms)
 Total time spent on the platform per participant
(both arms)
 Average time spent per page view on the platform
per participants (both arms)
 Total number of posts per participant made to the
peer-to-peer forum (intervention arm only)
 Total number of posts per participant made to the
Ask the Experts forum (intervention arm only)
Perceived acceptability will be determined through
interviewing a purposive sample of 20% of the participants
in the intervention arms of the trial after all the data
collection procedures (i.e. about 36 out of the 180, or less
should data saturation, that is no further data is being
collected that adds to the content of existing themes, be
reached in the iterative analysis process [38]). For the
individual interview, purposive sampling will be used to
identify participants to ensure representation of diverse
experiences and views from those with ethnic minority
backgrounds, different caregiving experiences and roles,
and usage patterns. The interview is designed to be semi-
structured and conducted over phone or Skype, suiting
the participants’ preference and convenience.
Data collection
Assessments will be completed online at baseline (i.e. no
more than two weeks prior to randomization and alloca-
tion), half-way through the intervention use (10-week),
post intervention (20-weeks), and 40-week follow-up. All
outcome measures are self-completed questionnaires as
described above. At each time point, we will invite the
participants to undertake an online assessment through
our secure platform. At study enrolment, we will also
collect data on participant’s demographic and caregivng-
related information (e.g. the gender of the cared-for
person, are they living together or separately, and how
much time they spend on caring for their loved one in
the previous week). At each assessment time point,
participants will receive up to six email-reminders over a
four-week window, linking them to an online platform
through which they can complete the assessment.
We will collect the usage data during the intervention
time (20 weeks) following completion of all outcome
data collection, i.e. at the end of 40 weeks. These data
will be collected from our intervention (and control)
platform which automatically record individuals’ usage.
On completion of each assessment, participants will be
emailed an Amazon voucher to thank for their time and
participation (i.e. £10 for the first, £5 for the second and
third respectively, and £10 for the fourth and last). We
will offer an additional £10 Amazon voucher for those
who give an interview. Figure 5 shows all the measures
used and data collection schedule.
Sample size
The trial sample size is calculated with reference to an
earlier study testing a digital health intervention targeting
siblings of individuals with first episode psychosis [39] and
the primary outcome measure data (i.e. WEMWBS [29]).
This study is powered to detect the minimum clinically
important difference of + 3 in WEMWBS which is consid-
ered a meaningful change post intervention between treat-
ment groups [31]. Using 80% power, significance level of
5% and an estimated SD of 9 from the E Sibling Project
RCT baseline results [13, 39], 143 carers per arm are
needed. With estimated 20% attrition, additional partici-
pants (n = 74), will be recruited, leading to an overall
sample size of 360 across both arms.
Random allocation
Participants who have completed baseline measures be-
fore the respective cohort starts will be randomized
using a 1:1 ratio to “COPe-support and usual care” ver-
sus “Control and usual care” by an online randomization
programme developed and hosted by King’s Clinical Tri-
als Unit. The algorithm for randomization will consist of
permuted blocks stratified by the gender. While there is
no established evidence of any carer sociodemographic
or caregiving-related factors having an effect on carers’
health outcomes, females (having a caregiving role or
not) are known to have worse outcomes in population
mental wellbeing research [11, 12, 40] and that partici-
pants in most prior research recruiting carers were
predominantly females.
Allocation concealment and blinding
We are unable to blind participants to their allocation as
they will realise that the control condition has much less
content, but both arms will have access to an online
resource bank and usual care. Nonetheless, all outcome
data collected use self-reported measures and direct
online input by participants. The study coordinator and
intervention (and control) online platform facilitator (JS)
cannot be blinded to the allocation because she needs to
adjust her facilitation according to the different content
of the two groups.
Data storage and security
All trial data as described above are collected through an
online system linked and integrated with the intervention
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platform. Only the Chief Investigation (JS) and core study
team members who have a role in either study facilitation
or data management will have direct access to such plat-
form and data. All data sets will be password protected.
To ensure confidentiality, data dispersed to trial statisti-
cians and wider project team members will be anon-
ymized of any identifying participant information.
Monitoring
Trial steering committee
The trial is overseen by an independent Trial Steering
Committee (TSC) comprising clinical-academic experts, an
independent trials statistician, and carers with experiential
expertise on the subject. The TSC provides governance and
guidance on the study delivery and progress. It provides a
monitoring and advice function for the safety and wellbeing
of the study participants. In view of the safety event data,
the TSC will consider the need for appointing a separate
Data Monitoring Committee (DMC) if necessary. In
addition, the TSC reviewed and approved the safety proto-
col, usage data definitions and statistical analysis plan.
Safety protocol
For this trial we have adapted the definition of adverse
events commonly used in conventional clinical trials.
In addition to adverse and serious adverse events, we
have devised a category labelled as “unintended conse-
quences”. These are summarized as follows:
 Unintended consequences (UCo) – incidents during
which participants’ use of the intervention (or control)
is interrupted and the potential distress caused is below
the threshold of that described in adverse event
category. Examples include participants forgetting their
log-in password, platform technical issues interrupting
Time point
STUDY PERIOD
Enrolment Allocation
Post-
allocation
Process 
evaluation
T-1 T0 T1 T2 T3 T4
Wk -18-0 Wk 0-2 Wk 
10
Wk 
20
Wk 
40
Wk 41-45
ENROLMENT
Eligibility 
screening X
Informed consent X
Sociodemographic 
& caring data X
Randomisation X
INTERVENTIONS COPe-support X X X
Control X X X
ASSESSMENTS
Caring-related 
data (including 
health & social 
service use)
X X X X
WEMWBS X X X X
MAKS X X X X
ECI X X X X
EQ-5D-5L X X X X
FQ X X X X
CWS X X X X
Perceived 
acceptability X
Usage data X
Fig. 5 Schedule of data collection. Detailed legend: T-1: Pre-randomisation; T0: baseline and randomisation; T1: mid-intervention; T2: end of
intervention; T3: 40-week follow up; T4: after follow-up outcome data collection; WEMWBS: Warwick-Edinburgh Mental Wellbeing Scale; MAKS:
Mental Health Knowledge Schedule; ECI: Experience of Caregiving Inventory; EQ-5D-5 L: EuroQol 5 level version of EQ-5D; FQ: Family
Questionnaire; CWS: Carer Wellbeing & Support Questionnaire
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delivering, or participants realizing their own unmet
needs in light of the intervention content.
 Adverse events (AE) - clear evidence of distress or
concerns of risk of harm towards participants or
others, resulting in needs for medical and/or mental
health support. However, there is no immediate or
serious threat of severe harm or risk of life
 Serious adverse events (SAE) – clear evidence of
immediate risk to life or welfare for the participants
or others.
Monitoring of all potential safety concerns will cover
both active monitoring of the online platform communi-
cations (e.g. participants’ post made on forums) and
query/concerns raised by participants (e.g. those who send
messages through our platform). In all circumstances, the
online facilitator will contact the participant concerned
and offer support through online or phone communica-
tion, in addition to signposting them to relevant local ser-
vices. In the unlikely event of SAEs, we will contact the
relevant local authorities (e.g. Police or social services) as
appropriate. Such safety monitoring and support mecha-
nisms are outlined in the participant information sheet.
Recording and coding of safety and untoward events
will be conducted on a continuous basis. These will also
be reported to the TSC prior to each of the biannual
TSC meeting or at an ad hoc basis if indicated, both for
consensus on coding and for safety monitoring. In the
event of SAEs, these need to be reported to both the
TSC chair and the sponsor within 48 hours.
Overall adverse effects, including the number of UCo,
AE, and SAE, will be recorded by number of events,
types and participants across both arms. In addition, we
will also record and report participant withdrawals from
the study.
Trial status and review
The trial is registered with the Current Controlled Trials
registration under the title “Randomised controlled trial of
COPe-support online resource for carers” (ISRCTN
89563420 [https://doi.org/10.1186/ISRCTN89563420], regis-
tration date: 02/03/2018). This study has also been reviewed
and approved by South Central – Oxford C Research Ethics
Committee (Reference: 18/SC/0104) and Health Research
Authority (Reference: IRAS 240005). Recruitment for the
trial commenced in March 2018 and will continue till early
2020. Participants are covered by indemnity and insurance
for harm associated with the protocol provided by the
Sponsor, St George’s, University of London.
Data analysis
Statistical analysis plan
The data analysis will be performed by the trial statisti-
cians who will be blind to randomized allocation for the
primary and secondary outcome analysis. Primary ana-
lyses will be undertaken on an intent-to treat (ITT)
basis, including all participants who were randomized
and supplied at least one post-randomisation measure at
10, 20, or 40 weeks, regardless of usage status or with-
drawal from the study. For the primary analysis, a linear
mixed model will be used. The model will include par-
ticipant and cohort as random effects and arm, time (10,
20, 40 weeks), the randomization stratification variable
gender as well as baseline score and a time-by-arm inter-
action. In order to improve precision we will adjust for
variables parent (Y/N) and living with the cared-for indi-
vidual (Y/N). The model’s assumptions for random ef-
fects distributions and residuals will be investigated. If
assumptions are not appropriate then transformation
will be considered. This model will be used to estimate
the mean difference and 95% CI in WEMWBS between
arms at the 20-week time point (i.e. primary endpoint)
though we will also explore and report the intervention
effect at week 10 and 40. The model will be fitted using
restricted maximum likelihood (REML). Secondary out-
come measures will be assessed using similar approach.
No interim analyses will be performed.
It is unlikely that missing baseline data will be problem-
atic for the analysis as baseline outcomes are required to
be collected prior to randomization. Further, as the ana-
lysis uses a mixed model which is efficient for missing data
under the missing at random assumption [41] no multiple
imputation will be performed. Sensitivity analysis will in-
clude exploring the mean WEMWBS score at each time
point if all participants with missing information was set
at the highest and lowest values seen in the dataset.
Further analysis after the analyses of primary and sec-
ondary outcomes will not be blind as this is not feasible.
The intervention effect in those that use COPe-support
(defined as having at least two logins) will be estimated
using a complier adjusted case analysis (CACE) with
“usage” treated as both a binary and ordinal variable.
Mediation measures analysis
A mediation measures analysis will be performed if there
is an intervention effect identified through the primary
analysis. We will explore if the effect worked through
the mechanisms underlying the intervention design and
as hypothesized by the adapted stress-appraisal-coping
model applied in family caregiving [22, 42]. The mecha-
nisms to be investigated include:
 Appraisal measured by ECI [8] – exploring the
effect of cognitive perception of the caregiving
situation as the stressor;
 Perceived support measured using the support
subscale of CWS [35] – via use of the peer-to-peer
forum and satisfaction with support received;
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 Mental health knowledge assessed by MAKS [34] –
via psychoeducation provided by the intervention.
The mediation analysis will allow us to decompose the
total observed intervention effect into mediated (indir-
ect) and non-mediated (direct) component and we will
use a structural equation modelling approach. Wellbeing
(WEMWBS) will be measured at 20 weeks and 40 weeks
and mediators at all time points (i.e. 10, 20 and 40
weeks) but “adjusted” for previous level and/or baseline
as indicative. We will fit each mediator in turn separately
and then undertake a multiple mediation analysis. A full
statistical analysis plan will be available on request from
the lead trial statistician (VC).
Qualitative data analysis
Transcribed qualitative data collected on participants’
experience in using COPe-support will be analysed using
the framework analysis method [38, 43], in order to ex-
plore participants’ experiences and understanding of the
processes whereby the intervention might bring about
change.
Reporting and dissemination
The trial will be reported following the Consolidated
Standards of Reporting Trials guideline [44]. We aim to
disseminate the results of this study widely, through
publication in peer-reviewed journals and presentations
at national and international conferences. Our study
website (www.cope-support.org) will serve as a commu-
nication portal providing updates and outputs from the
study and links to all publications.
Discussion
Despite clinical guidelines recommending psychoeduca-
tion, especially those delivered to carers using a group
format as an effective support for carers, its provision
remains scarce [2, 16]. Caregiving, although bringing
positives to both personal experiences and bonds with
significant others, often causes burden and distress in
carers. Given carers’ wellbeing is correlated with their
caregiving capacity, which can also affect the quality of
support the cared-for person receives, it is paramount
that carers have access to an effective treatment. Digital
mental health interventions delivered through the inter-
net offer novel and flexible solutions to disseminating
evidence-based psychosocial interventions to carers [17].
The trial of COPe-support represents one step closer to
providing carers access to digital mental health
interventions.
This study will provide valuable evidence regarding
the effectiveness of a web-based psychoeducation inter-
vention integrated with peer support for carers. Despite
the proliferation of digital mental health interventions,
there is scarce research on the effectiveness in the field
of psychosis [17]. Meanwhile, carers’ need for such an
intervention maybe particularly high given their diverse
needs and many other commitments, such as work and
their own families. Digital interventions offer advantages
in that they increase user autonomy and anonymity,
which may be important as stigma and lack of know-
ledge of, or access to services can impact upon help-
seeking behaviour in carers [17, 45]. An intervention de-
livered through the internet may also offer the only
means to provide, through the healthcare system, highly
individualised care to a critical mass of carers [46].
While optimising all the potentials the internet offers
into the study and intervention design, we are aware of
the challenges common amongst digital interventions
and online trials. Because digital interventions allow
their users a self-directed approach in using the content,
intervention usage or adherence is often much more
heterogenous [23, 47]. Trial attrition and disengagement
are also expected issues [23, 25]. To account for poten-
tial drop out and disengagement, we have devised a fa-
cilitation protocol alongside the delivery of COPe-
support, drawing strategies and ideas through extensive
consultations with carers and a usability study on the
intervention-prototype [22, 30]. We have used conserva-
tive recruitment and retention estimation taking lessons
from the few other similar trials with carer populations
[39, 48]. Furthermore, we have also used a trial design
that includes an internal pilot with keen monitoring on
these parameters. We will review and revise our strat-
egies at end of pilot to scale up to the full trial accord-
ingly. In terms of the usage issue, we have put in place
several strategies. We recognise COPe-support is a novel
intervention delivered through the internet, and as such
a conventional “adherence threshold” or per protocol
usage pattern would not be appropriate. As no
literature-based usage was identified [6], we consulted
experts through experience and clinical and academic
experts in the field to identify and define the meaningful
usage definitions used in the study protocol. We are par-
ticularly interested in understanding (1) how carers will
use COPe-support, and (2) if there is a differential inter-
vention effects in those who have decided to log-in
COPe-support twice or more and use it in different ex-
tent. For such goals, we consider it important to carry
out the “complier average causal effect” (CACE) analysis
[23, 27]. This is because the primary analysis using the
ITT model, although the gold standard, will have
neglected the usage effects, if any.
To our knowledge, the current study is one of the first
to test online psychoeducation integrated with peer sup-
port for psychosis carers, compared to an attention con-
trol. In addition to enhance participant retention, we are
mindful to design the control to match online resources
Sin et al. BMC Psychiatry          (2020) 20:129 Page 12 of 14
typically available to carers as part of usual care.
Although the choice of an attention control may reduce
effect sizes, this stricter examination should result in
stronger arguments for the use of interactive and moder-
ated web-based interventions (such as COPe-support),
rather than non-interactive information passively deli-
vered through the internet.
Abbreviations
AE: Adverse event; CACE: Complier adjusted case analysis; COPe-
support: Carers fOr People with Psychosis e-support; CWS: Carer Wellbeing &
Support Questionnaire; ECI: Experience of Caregiving Inventory; EFFIP: E-
support for Families and Friends of Individuals affected by Psychosis Project;
EQ-5D-5L: EuroQol 5 level version of EQ-5D; FQ: Family Questionnaire;
ITT: Intention-to-treat; MAKS: Mental Health Knowledge Schedule;
RCT: Randomized controlled trial; SAE: Serious adverse event; TSC: Trial
Steering Committee; UCo: Unintended consequence; UC: Usual care;
VLE: Virtual learning environment; WEMWBS: Warwick-Edinburgh Mental
Wellbeing Scale
Acknowledgements
The authors thank all the input and contributions from the Expert Advisory
Group members who helped design COPe-support and the members of the
Project Reference Group which provides oversight of the overall EFFIP pro-
ject delivery. They are: Ellen Harris; Jacqueline Marks; Angela Ryan; Storm
Ryan; Lana Samuels; Dr. Clive Travis; Leigh Wallbank; and Dr. Elen Williams
(see http://cope-support.org/team/).
We are very grateful to all the members of the Trial Steering Committee,
including, Paul Kenny, Eva Klamerus, Christine Lewis, Dr. Bryn Lloyd-Evans
(Chair), Dr. Louise Marston, and Professor Jo Smith.
We thank all the members who help run the Ask the Experts forum. They
include: Ana Maria Corredor Collazos; David Coughlin; Dr. Ranjita Dhital; Sian
Evans; Dr. Ban Haider; Julia Heathcote; Dr. Claire Henderson; Dr. Sarah
Mansfield; Dr. Aileen O’Brien; Mona Qassim; Juliet Sserunkuma; Dr. Clive
Travis; and Dr. Elen Williams.
For recruiting participants into the study, the project team acknowledges the
support of the National Institute for Health Research, through the Clinical
Research Network (Division 4).
Authors’ contributions
JS conceived of the study and initiated the study design with supervision
from CH and SG. JS is the grant holder. JS, CH, SG, LW, ASH, DPS further
developed the design and its implementation. VC, TC, JE act as trial
statisticians and led the development of the statistical analysis plan. RB
provided input to support study conduct and data management. All authors
read and approved the final manuscript.
Funding
This trial, as part of a bigger research programme entitled EFFIP (E-support
for Families and Friends of Individuals affected by Psychosis) is funded by
the National Institute for Health Research under its Post Doctoral Research
Fellowship (awarded to Dr. Jacqueline Sin, reference: PDF-2015-08-035). The
study was peer reviewed by the funding body.
The views expressed in this publication are those of the author(s) and not
necessarily those of the NHS, the National Institute for Health Research or
the Department of Health and Social Care. The funder had no involvement
in the design of this study and will not have any role during its execution,
analyses or interpretation of data, writing the manuscript, and decision to
submit the manuscript for publication.
Availability of data and materials
The datasets generated during and/or analysed during the current study will
not be shared or publicly available due to conditions on participant consent
and other ethical restrictions, as registration of the trial predated open data
recommendations.
Ethics approval and consent to participate
This study has been reviewed and approved by South Central – Oxford C
Research Ethics Committee (Reference: 18/SC/0104) and Health Research
Authority (Reference: IRAS 240005). Prior to study participation all participants
are required to view and give consent online to the information that was
provided in the Participant Information Sheet.
Consent for publication
Not applicable.
Competing interests
All authors declare that they have no competing interests.
Author details
1Population Health Research Institute, St George’s, University of London,
Cranmer Terrace, London SW17 0RE, England, UK. 2School of Psychology &
Clinical Language Sciences, University of Reading, Earley Gate, Reading RG6
6AL, England, UK. 3Health Service & Population Research Department, King’s
College London, Institute of Psychiatry, Psychology & Neuroscience, De
Crespigny Park, London SE5 8AF, England, UK. 4Imperial Clinical Trials Unit,
School of Public Health, Imperial College London, Stadium House, 68 Wood
Lane, London, England W12 7RH, UK. 5Department of Clinical Sciences,
Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA,
England, UK. 6Institute of Medical and Biomedical Education, St George’s,
University of London, Cranmer Terrace, London SW17 0RE, England, UK.
Received: 31 January 2020 Accepted: 3 March 2020
References
1. Shahly V, Chatterji S, Gruber MJ, Al-Hamzawi A, Alonso J, Andrade LH,
Angermeyer MC, Bruffaerts R, Bunting B, Caldas-de-Almeida JM, et al. Cross-
national differences in the prevalence and correlates of burden among
older family caregivers in the World Health Organization (WMH) surveys.
Psychol Med. 2013;43(4):865–79.
2. NICE. Psychosis and schizophrenia in adults: treatment and management
(National Clinical Guideline no. 178). London: National Collaboration Centre
for Mental Health; 2014.
3. The Schizophrenia Commission. The Abandoned Illness - A report by the
Schizophrenia Commission. London: Rethink Mental Illness; 2012.
4. Carers Trust. Key facts about carers and the people they care for [https://
carers.org/key-facts-about-carers-and-people-they-care]. Last accessed 20th
Dec 2019.
5. Sin J, Norman I. Psychoeducational interventions for families of individuals
with schizophrenia: a mixed method systematic review. J Clin Psychiatry.
2013;74(12):e1145–62.
6. Sin J, Gillard S, Spain D, Cornelius V, Chen T, Henderson C. Effectiveness of
psychoeducational interventions for family carers of people with psychosis:
a systematic review and meta-analysis. Clin Psychol Rev. 2017;56:13–24.
7. Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for
schizophrenia Cochrane Database of Systematic Reviews 2010 (Issue 12. Art.
No.: CD000088).
8. Szmukler G, Burgess P, Herrman H, Benson A, Colusa S, Bloch S. Caring for
relatives with serious mental illness; the development of the experience of
caregiving inventory. Soc Psychiatry Psychiatr Epidemiol. 1996;31:137–48.
9. Kuipers E, Raune D. The early development of EE and burden in the families
of first onset psychosis. In: Birchwood M, Fowler D, editors. Early
Intervention in Psychosis: A Guide to Concepts, Evidence and Interventions.
Chichester: Wiley; 2000. p. 128–40.
10. Smith L, Onwumere J, Craig T, McManus S, Bebbington P, Kuipers E. Mental
and physical illness in caregivers: results from an English national survey
sample. Br J Psychiatry. 2014;205:197–203.
11. Beaumont J, Thomas H. ONS. Measuring National Well-being, Health, 2012.
London: Office for National Statistics; 2012.
12. McManus S, Bebbington P, Jenkins R, Brugha T, editors. Mental health and
wellbeing in England: adult psychiatric morbidity survey 2014. Leeds: NHS
Digital; 2016.
13. Sin J, Murrells T, Spain D, Norman I, Henderson C. Wellbeing, mental health
knowledge and caregiving experiences of siblings of people with psychosis,
compared to their peers and parents: an exploratory study. Soc Psychiatry
Psychiatr Epidemiol. 2016;51:1247–55.
14. Bebbington PE, Kuipers E. The predictive utility of expressed emotion in
schizophrenia. Psychol Med. 1994;24:707–18.
Sin et al. BMC Psychiatry          (2020) 20:129 Page 13 of 14
15. Schizophrenia RAJ. In: Cucciare MA, Weingardt KR, editors. Using
Technology to Support Evidence-Based Behavioural Health Practices - A
Clinician's Guide. New York: Routledge; 2010. p. 69–90.
16. Yesufu-Udechuku A, Harrison B, Mayo-Wilson E, Young N, Woodhams P,
Shiers D, Kuipers E, Kendall T. Interventions to improve the experience of
caring for people with severe mental illness: systematic review and meta-
analysis. Br J Psychiatry. 2015;206:268–74.
17. Sin J, Henderson C, Spain D, Cornelius V, Chen T, Gillard S. eHealth
interventions for family carers of people with long term illness: a promising
approach? Clin Psychol Rev. 2018;60:109–25.
18. Powell J, Chiu T, Eysenbach G. A systematic review of networked
technologies supporting carers of people with dementia. J Telemed
Telecare. 2008;14:154–6.
19. Sherifali D, Usman Ali M, Ploeg J, Markle-Reid M, Valaitis R, Bartholomew A,
Fitzpatrick-Lewis D, McAiney C. Impact of internet-based interventions on
caregiver mental health: systematic review and meta-analysis. J Med
Internet Res. 2018;20(7):e10668.
20. Vaughan C, Trail TE, Mahmud A, Dellva S, Tanielian T, Friedman E. Informal
caregivers' experiences and perceptions of a web-based peer support
network: mixed-methods study. J Med Internet Res. 2018;20(8):e257.
21. Grover M, Naumann U, Mohammad-Dar L, Glennon D, Ringwood S, Eisler I,
Williams C, Treasure J, Schmidt U. A randomized controlled trial of an
internet-based cognitive-behavioural skills package for carers of people with
anorexia nervosa. Psychol Med. 2011;41(12):2581–91.
22. Sin J, Henderson C, Woodham LA, Sesé Hernández A, Gillard S. A
multicomponent eHealth intervention for family carers for people affected
by psychosis: a coproduced design and build study. J Med Internet Res.
2019;21(8):e14374.
23. Murray E, Khadjesari Z, White IR, Kalaitzaki E, Godfrey C, McCambridge J,
Thompson SG, Wallace P. Methodological challenges in online trials. J Med
Internet Res. 2009;11(2):e9.
24. Christensen H, Griffiths KM, Farrer L. Adherence in internet intervention for
anxiety and depression: systematic review. J Med Internet Res. 2009;11(2):1–16.
25. Eysenbach G. The law of attrition. J Med Internet Res. 2005;7(1):e11.
26. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias.
Dimensions of methodological quality associated with estimates of
treatment effects in controlled trials. JAMA. 1995;273(5):408–12.
27. White IR. Uses and limitations of randomization-based efficacy estimators.
Stat Methods Med Res. 2005;14(4):327–47.
28. Eysenbach G. CONSORT-EHEALTH Group. CONSORT-EHEALTH: Improving
and Standardizing Evaluation Reports of Web-based and Mobile Health
Interventions. J Med Internet Res. 2011;13(4):e126.
29. Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Welch S, Parkinson J, Secker
J, Stewart-Brown S. The Warwick-Edinburgh mental Wellbeing scale
(WEMWBS): development and UK validation. Health Qual Life Outcome.
2007;5:63.
30. Sin J, Woodham LA, Henderson C, Williams E, Sese Hernandez A, Gillard S.
Usability evaluation of an eHealth intervention for family carers of
individuals affected by psychosis: a mixed-method study. Digit Health. 2019;
5:2055207619871148.
31. Bryson A, Green F, Bridges S, Craig R. Well-being, health and work. In: MJ
CR, editor. Health survey for England 2010. London: The Health and Social
Care Information Centre. p. 2011. Chapter 7.
32. Bridges S. Wellbeing. In: Craig R, Mindell J, editors. Health Survey for
England 2012. London: The Health and Social Care Information Centre. p.
2013. Chapter 6.
33. Maheswaran H, Weich S, Powell J, Stewart-Brown S. Evaluating the
responsiveness of the Warwick Edinburgh mental well-being scale
(WEMWBS): group and individual level analysis. Health Qual Life Outcomes.
2012;10(1):156.
34. Evans-Lacko S, Little K, Meltzer H, Rose D, Rhydderch D, Henderson C,
Thornicroft G. Development and psychometric properties of the mental
health knowledge schedule (MAKS). Can J Psychiatr. 2010;55:440–8.
35. Quirk A, Smith S, Hamilton S, et al. The development and validation of the
Carer well-being and support (CWS) questionnaire. Ment Health Rev. 2012;
17(3):128–38.
36. Wiedemann G, Rayki O, Feinstein E, Hahlweg K. The family questionnaire :
development and validation of a new self-report scale for assessing
expressed emotion. Psychiatry Res. 2002;109:265–79.
37. Devlin NJ, Krabbe PFM. The development of new research methods for the
valuation of ED-5D-5L. Eur J Health Econ. 2013;14(S1):S1–3.
38. Ritchie J, Lewis J, McNaughton Nicholls C, Ormston R, editors. Qualitative
research practice: a guide for social science students and researchers. 2nd
ed. Los Angeles: Sage; 2014.
39. Sin J, Henderson C, Pinfold V, Norman I. The E sibling project - exploratory
randomised controlled trial of an online multi-component
psychoeducational intervention for siblings of individuals with first episode
psychosis. BMC Psychiatry. 2013;13:123.
40. NatCen Social Research, UCL. Health Survey for England 2017. London:
Health and Social Care Information Centre; 2018.
41. White IR, Horton NJ, Carpenter J, Pocock SJ. Strategies for intention to treat
analysis in randomised trials with missing outcome data. BMJ. 2011;342:d40.
42. Szmukler G. From family 'burden' to caregiving. Psychiatr Bull. 1996;20:449–51.
43. Spencer LS, Ritchie J, Ormston R, O'Connor W, Barnard M. Analysis:
principles and processes. In: Ritchie J, Lewis J, McNaughton Nicholls C,
Ormston R, editors. Qualitative Research Practice: A Guide for Social Science
Students and Researchers. London: SAGE Publications Ltd.; 2014.
44. Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT NPT Group.
CONSORT Statement for Randomized Trials of Nonpharmacologic
Treatments: A 2017 Update and a CONSORT extension for
nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.
45. Henderson C, Thornicroft G. Evaluation of the Time to Change programme
in England 2008–2011. Br J Psychiatry. 2013;202(Supplement 55):s45–8.
46. Andrews G, Titov N. Treating people you never see: internet-based
treatment of the internalising mental disorders. Aust Health Rev. 2010;34(2):
144–7.
47. Powell J, Hamborg T, Stallard N, Burls A, McSorley J, Bennett K, Griffiths KM,
Christensen H. Effectiveness of a web-based cognitive-behavioural tool to
improve mental well-being in the general population: randomised
controlled trial. J Med Internet Res. 2013;15(1):e2.
48. Lobban F, Robinson H, Appelbe D, Barraclough J, Bedson E, Collinge L,
Dodd S, Flowers S, Honary M, Johnson S, et al. Protocol for an online
randomised controlled trial to evaluate the clinical and cost-effectiveness of
a peer-supported self-management intervention for relatives of people with
psychosis or bipolar disorder: relatives education and coping toolkit
(REACT). BMJ Open. 2017;7:e016965.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Sin et al. BMC Psychiatry          (2020) 20:129 Page 14 of 14
